PaoloAnderliniMD

Oncology • Houston, TX

Physician

Join to view full profile

Dr. Anderlini is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Anderlini's full profile

Already have an account?

Office
1515 Holcombe Blvd
Houston, TX 77030
Phone+1 713-792-6161

Education & Training

University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1993 - 1996
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1990 - 1993
University of Modena Faculty of MedicineClass of 1986

Certifications & Licensure

FL State Medical License 2021 - Present
TX State Medical License 1997 - 2024
OK State Medical License 2020 - 2021
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201) Start of enrollment: 2004 Jan 01
Completed
Phase 3
Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301) Start of enrollment: 2006 Jan 01
Completed
Phase 1, Phase 2
Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease Start of enrollment: 2005 Jul 01
Completed
Phase 2
Use and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia Patients Start of enrollment: 2003 Aug 01
Completed
Not Applicable
Allogeneic Blood Stem Cell Transplantation Start of enrollment: 1998 Jan 01
Completed
Not Applicable
Purine Analog-Based Conditioning in Patients With Severe Aplastic Anemia Start of enrollment: 2000 Dec 01
Completed
Not Applicable
Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation From HLA-Compatible Unrelated Donors in Severe Aplastic Anemia Start of enrollment: 2006 Feb 01
Join now to see all

Publications & Presentations

PubMed

Outcomes of toxoplasmosis after allogeneic hematopoietic stem cell transplantation and the role of antimicrobial prophylaxis.
Alexandre E Malek, Taha Al-Juhaishi, Denái R Milton, Jeremy L Ramdial, May Daher
Bone Marrow Transplantation. 2024-05-01
6 citations
Vorinostat Combined with Busulfan, Fludarabine, and Clofarabine Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leuk...
Gheath Alatrash, Chantal Saberian, Roland Bassett, Peter F Thall, Celina Ledesma
Transplantation and Cellular Therapy. 2022-08-01
10 citations
Haploidentical versus Matched Unrelated versus Matched Sibling Donor Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide.
Rohtesh S Mehta, Rima M Saliba, Sassine Ghanem, Amin M Alousi, Gabriela Rondon
Transplantation and Cellular Therapy. 2022-07-01

Professional Memberships

American Society of Clinical Oncology - ASCO
Member